- Filed
- Apr 24, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 15, 2025 | 908.47M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $12.85B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $12.85B |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $2.24B |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $4.38B |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $2.76B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $3.2B |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $16.41B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $16.9B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $2.49B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $3.64B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $17.35B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $18.61B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $13.09B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $15.03B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $33.76B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $35.51B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 917M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $3M |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $1.18B |
| Capex | Q1 2025 · Mar 31, 2024 | $1.25B |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $1.02B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $1.20 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $1.21 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $455M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $478M |
| Net Income | Q1 2025 · Mar 31, 2024 | $1.11B |
| Operating Income | Q1 2025 · Mar 31, 2024 | $1.29B |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $2.1B |
| Revenue | Q1 2025 · Mar 31, 2024 | $3.66B |